Workflow
Harpoon Therapeutics(HARP) - 2020 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or Delaware 47-3458693 (I.R.S. Employer Identification No.) 131 Oyster Point Blvd, Suite 131 South San Francisco, CA 94080 (Address of principal executive offices) Registrant's telephone number, including area code: (650) 443-7400 Securities registered pursuant to Section 12(b) of t ...